National Bank Of Canada Axsome Therapeutics, Inc. Transaction History

National Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$69.39 - $97.64 $693 - $976	10 Added 1.67%	610 $48,000
Q4 2023 Feb 06, 2024	SELL	$57.42 - $83.61 $3.42 Million - $4.98 Million	-59,603 Reduced 99.0%	600 $47,000
Q3 2023 Oct 10, 2023	SELL	$69.25 - $82.21 $638,485 - $757,976	-9,220 Reduced 13.28%	60,203 $4.21 Million
Q2 2023 Jul 26, 2023	BUY	$58.41 - $90.35 $4.05 Million - $6.27 Million	69,423 New	69,423 $4.99 Million

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.74B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

Stay updated on National Bank Of Canada with notifications on news.